Cell Medicine, 2010 · DOI: 10.3727/215517910X516673 · Published: January 1, 2010
Cell-based restorative treatment has become a new trend, and increasing data worldwide have strongly proven that it has a pivotal therapeutic value in CNS disease. Functional neurorestoration has been achieved to a certain extent in the CNS clinically. Based on the complexity of the processes of demyelination and remyelination, degeneration and regeneration, damage and repair, functional loss and recovery, it would be expected that effective therapeutic approaches will require a combination of strategies encompassing neuroplasticity, immunomodulation, neuroprotection, neurorepair, neuroreplacement, and neuromodulation.
The review provides a comprehensive overview of various cell-based therapies and their potential for clinical translation in treating CNS diseases.
Highlights the need for combined strategies, encompassing neuroplasticity, immunomodulation, neuroprotection, neurorepair, neuroreplacement, and neuromodulation, for effective therapeutic approaches.
Emphasizes the importance of solving unanswered questions regarding cell sources, therapeutic time windows, patient selection, and optimal routes for cell transplantation to improve treatment efficacy.